{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:19:23Z","timestamp":1756383563146},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,9]]},"DOI":"10.7759\/cureus.22045","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T12:01:36Z","timestamp":1644408096000},"source":"Crossref","is-referenced-by-count":1,"title":["Exanthematous Drug Eruption to Intravenous Iron: A Case Report"],"prefix":"10.7759","author":[{"given":"Shilpa S","family":"Mantri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niraj","family":"Ballam Nagaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinjal","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haris","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Iron Deficiency Anemia","author":"Warner MJ and Kamran MT","year":"2021","unstructured":"Warner MJ and Kamran MT. Iron Deficiency Anemia. StatPearls Publishing LLC., Treasure Island; 2021."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.338","article-title":"Clinical use of intravenous iron: administration, efficacy, and safety","volume":"2010","author":"Auerbach M","year":"2010","unstructured":"Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program. 2010, 2010:338-47. 10.1182\/asheducation-2010.1.338","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.111492","article-title":"Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management","volume":"99","author":"Rampton D","year":"2014","unstructured":"Rampton D, Folkersen J, Fishbane S, et al.. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica. 2014, 99:1671-6. 10.3324\/haematol.2014.111492","journal-title":"Haematologica"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.15572","article-title":"Comparative risk of anaphylactic reactions associated with intravenous iron products","volume":"314","author":"Wang C","year":"2015","unstructured":"Wang C, Graham DJ, Kane RC, et al.. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA. 2015, 314:2062-8. 10.1001\/jama.2015.15572","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13268","article-title":"Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management","volume":"172","author":"Szebeni J","year":"2015","unstructured":"Szebeni J, Fishbane S, Hedenus M, et al.. Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. Br J Pharmacol. 2015, 172:5025-36. 10.1111\/bph.13268","journal-title":"Br J Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes ER","year":"2005","unstructured":"Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005, 5:309-16. 10.1097\/01.all.0000173785.81024.33","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00314.x","article-title":"Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran","volume":"61","author":"Michael B","year":"2002","unstructured":"Michael B, Coyne DW, Fishbane S, et al.. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int. 2002, 61:1830-9. 10.1046\/j.1523-1755.2002.00314.x","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.11.028","article-title":"Safety of intravenous iron following infusion reactions","volume":"9","author":"Stojanovic S","year":"2021","unstructured":"Stojanovic S, Graudins LV, Aung AK, Grannell L, Hew M, Zubrinich C. Safety of intravenous iron following infusion reactions. J Allergy Clin Immunol Pract. 2021, 9:1660-6. 10.1016\/j.jaip.2020.11.028","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1104080","article-title":"Clinical practice. Exanthematous drug eruptions","volume":"366","author":"Stern RS","year":"2012","unstructured":"Stern RS. Clinical practice. Exanthematous drug eruptions. N Engl J Med. 2012, 366:2492-501. 10.1056\/NEJMcp1104080","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan HL","year":"1990","unstructured":"Chan HL, Stern RS, Arndt KA, et al.. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol. 1990, 126:43-47. 10.1001\/archderm.1990.01670250049006","journal-title":"Arch Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08156.x","article-title":"Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR)","volume":"157","author":"Sidoroff A","year":"2007","unstructured":"Sidoroff A, Dunant A, Viboud C, et al.. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007, 157:989-96. 10.1111\/j.1365-2133.2007.08156.x","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5070\/D33wd095bt","article-title":"Viral exanthems","volume":"9","author":"Scott LA","year":"2003","unstructured":"Scott LA, Stone MS. Viral exanthems. Dermatol Online J. 2003, 9:4. 10.5070\/D33wd095bt","journal-title":"Dermatol Online J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000145","article-title":"Viral exanthems","volume":"28","author":"Keighley CL","year":"2015","unstructured":"Keighley CL, Saunderson RB, Kok J, Dwyer DE. Viral exanthems. Curr Opin Infect Dis. 2015, 28:139-50. 10.1097\/QCO.0000000000000145","journal-title":"Curr Opin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr T","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010, 5:39. 10.1186\/1750-1172-5-39","journal-title":"Orphanet J Rare Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32832d565c","article-title":"Role of T cells in nonimmediate allergic drug reactions","volume":"9","author":"Rozieres A","year":"2009","unstructured":"Rozieres A, Vocanson M, Sa\u00efd BB, Nosbaum A, Nicolas JF. Role of T cells in nonimmediate allergic drug reactions. Curr Opin Allergy Clin Immunol. 2009, 9:305-10. 10.1097\/ACI.0b013e32832d565c","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.11.048","article-title":"Immune pathomechanism of drug hypersensitivity reactions","volume":"127","author":"Pichler WJ","year":"2011","unstructured":"Pichler WJ, Naisbitt DJ, Park BK. Immune pathomechanism of drug hypersensitivity reactions. J Allergy Clin Immunol. 2011, 127:S74-81. 10.1016\/j.jaci.2010.11.048","journal-title":"J Allergy Clin Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.27","article-title":"Immune mechanisms in drug allergy","volume":"55","author":"Roujeau JC","year":"2006","unstructured":"Roujeau JC. Immune mechanisms in drug allergy. Allergol Int. 2006, 55:27-33. 10.2332\/allergolint.55.27","journal-title":"Allergol Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02677.x","article-title":"NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions","volume":"66","author":"Schlapbach C","year":"2011","unstructured":"Schlapbach C, Zawodniak A, Irla N, et al.. NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions. Allergy. 2011, 66:1469-76. 10.1111\/j.1398-9995.2011.02677.x","journal-title":"Allergy"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity","volume":"216","author":"Szebeni J","year":"2005","unstructured":"Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology. 2005, 216:106-21. 10.1016\/j.tox.2005.07.023","journal-title":"Toxicology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-018-0273-1","article-title":"Roadmap and strategy for overcoming infusion reactions to nanomedicines","volume":"13","author":"Szebeni J","year":"2018","unstructured":"Szebeni J, Simberg D, Gonz\u00e1lez-Fern\u00e1ndez \u00c1, Barenholz Y, Dobrovolskaia MA. Roadmap and strategy for overcoming infusion reactions to nanomedicines. Nat Nanotechnol. 2018, 13:1100-8. 10.1038\/s41565-018-0273-1","journal-title":"Nat Nanotechnol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00002142-200108000-00007","article-title":"Safety of magnetic resonance contrast media","volume":"12","author":"Runge VM","year":"2001","unstructured":"Runge VM. Safety of magnetic resonance contrast media. Top Magn Reson Imaging. 2001, 12:309-14. 10.1097\/00002142-200108000-00007","journal-title":"Top Magn Reson Imaging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00586-8","article-title":"Eczematous drug eruptions","volume":"22","author":"Blum AE","year":"2021","unstructured":"Blum AE, Burgin S. Eczematous drug eruptions. Am J Clin Dermatol. 2021, 22:349-66. 10.1007\/s40257-021-00586-8","journal-title":"Am J Clin Dermatol"},{"key":"ref24","article-title":"Topical corticosteroids in dermatology","volume":"8","author":"Tadicherla S","year":"2009","unstructured":"Tadicherla S, Ross K, Shenefelt PD, Fenske NA. Topical corticosteroids in dermatology. J Drugs Dermatol. 2009, 8:1093-105.","journal-title":"J Drugs Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck J","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008, 58:33-40. 10.1016\/j.jaad.2007.08.039","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/83508-exanthematous-drug-eruption-to-intravenous-iron-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:45Z","timestamp":1707507465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/83508-exanthematous-drug-eruption-to-intravenous-iron-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.22045","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,9]]}}}